Free Trial

Kyle Mikson Analyst Performance

Managing Director, Senior Research Analyst at Canaccord Genuity Group

Kyle Mikson is a stock analyst at Canaccord Genuity Group focused in the medical sector, covering 16 publicly traded companies. Over the past year, Kyle Mikson has issued 34 stock ratings, including buy and hold recommendations. While full access to Kyle Mikson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kyle Mikson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
50 Last 3 Years
Buy Recommendations
77.78% 35 Buy Ratings
Companies Covered
16 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy77.8%35 ratings
Hold22.2%10 ratings
Sell0.0%0 ratings

Out of 45 total stock ratings issued by Kyle Mikson at Canaccord Genuity Group, the majority (77.8%) have been Buy recommendations, followed by 22.2% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
16 companies

Kyle Mikson, an analyst at Canaccord Genuity Group, currently covers 16 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
15 companies
93.8%
Computer and Technology
1 company
6.3%

Kyle Mikson of Canaccord Genuity Group specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
4 companies
25.0%
MEDICAL SERVICES
3 companies
18.8%
MED INSTRUMENTS
3 companies
18.8%
MEDICAL INFO SYS
2 companies
12.5%
MED PRODUCTS
2 companies
12.5%
ELEC COMP - SEMIC
1 company
6.3%
SURGICAL & MEDICAL INSTRUMENTS
1 company
6.3%

Kyle Mikson's Ratings History at Canaccord Genuity Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
GRAIL, Inc. stock logo
GRAL
GRAIL
10/22/2025Boost Price Target$81.33$85.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
10/20/2025Set Price Target$120.94$155.00Buy
Veracyte, Inc. stock logo
VCYT
Veracyte
10/20/2025Initiated Coverage$35.83$40.00Hold
Tempus AI, Inc. stock logo
TEM
Tempus AI
10/20/2025Initiated Coverage$87.78$110.00Buy
Tempus AI, Inc. stock logo
TEM
Tempus AI
10/20/2025Initiated Coverage$84.07$110.00Buy
GeneDx Holdings Corp. stock logo
WGS
GeneDx
10/20/2025Initiated Coverage$118.88$155.00Buy
Natera, Inc. stock logo
NTRA
Natera
10/14/2025Reiterated Rating$172.81$200.00Buy
GRAIL, Inc. stock logo
GRAL
GRAIL
10/3/2025Boost Price Target$72.37$75.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
9/26/2025Boost Price Target$60.18$75.00Buy
Biodesix, Inc. stock logo
BDSX
Biodesix
9/19/2025Set Price Target$6.77$20.00Buy
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
9/9/2025Reiterated Rating$1.08$1.00Hold
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
9/9/2025Reiterated Rating$24.05$37.00Buy
10x Genomics stock logo
TXG
10x Genomics
8/11/2025Set Price Target$12.41$16.00
Quanterix Corporation stock logo
QTRX
Quanterix
8/11/2025Reiterated Rating$4.75$5.00Hold
Illumina, Inc. stock logo
ILMN
Illumina
8/1/2025Boost Price Target$96.17$105.00Hold
Exagen Inc. stock logo
XGN
Exagen
7/30/2025Boost Price Target$8.45$11.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
6/11/2025Boost Price Target$87.98$99.00Hold
Biodesix, Inc. stock logo
BDSX
Biodesix
5/14/2025Lower Price Target$4.40$30.00Buy
Exagen Inc. stock logo
XGN
Exagen
5/13/2025Boost Price Target$5.48$8.00Buy
Quanterix Corporation stock logo
QTRX
Quanterix
5/13/2025Lower Price Target$4.75$12.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
5/12/2025Lower Price Target$75.76$87.00Hold
10x Genomics stock logo
TXG
10x Genomics
5/12/2025Lower Price Target$9.44$15.00Buy
Castle Biosciences, Inc. stock logo
CSTL
Castle Biosciences
5/6/2025Lower Price Target$18.75$37.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
5/1/2025Boost Price Target$48.89$65.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
4/29/2025Lower Price Target$77.22$92.00Hold
Biodesix, Inc. stock logo
BDSX
Biodesix
4/29/2025Lower Price Target$11.40$50.00Buy
GRAIL, Inc. stock logo
GRAL
GRAIL
4/21/2025Initiated Coverage$27.00$32.00Buy
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
4/10/2025Reiterated Rating$1.38$3.00Buy
Quanterix Corporation stock logo
QTRX
Quanterix
3/18/2025Lower Price Target$7.28$15.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
3/11/2025Lower Price Target$85.97$115.00Hold
Natera, Inc. stock logo
NTRA
Natera
2/26/2025Reiterated Rating$161.43$180.00Buy
Guardant Health, Inc. stock logo
GH
Guardant Health
2/24/2025Boost Price Target$42.87$60.00Buy
10x Genomics stock logo
TXG
10x Genomics
2/13/2025Lower Price Target$11.94$18.00Buy
Illumina, Inc. stock logo
ILMN
Illumina
2/7/2025Lower Price Target$112.34$135.00Hold